» Articles » PMID: 9396010

Nicotinic Acetylcholine Receptors in Health and Disease

Overview
Journal Mol Neurobiol
Date 1997 Dec 13
PMID 9396010
Citations 99
Authors
Affiliations
Soon will be listed here.
Abstract

Nicotinic acetylcholine receptors (AChRs) are a family of acetylcholine-gated cation channels that form the predominant excitatory neurotransmitter receptors on muscles and nerves in the peripheral nervous system. AChRs are also expressed on neurons in lower amounts throughout the central nervous system. AChRs are even being reported on unexpected cell types such as keratinocytes. Structures of these AChRs are being determined with increasing precision, but functions of some orphan subunits are just beginning to be established. Functional roles for postsynaptic AChRs in muscle are well known, but in neurons the post-, peri-, extra-, and presynaptic roles of AChRs are just being revealed. Pathogenic roles of AChRs are being discovered in many diseases involving mechanisms ranging from mutations, to autoimmune responses, to the unknown; involving cell types ranging from muscles, to neurons, to keratinocytes; and involving signs and symptoms ranging from muscle weakness to epilepsy, to neurodegenerative disease, to psychiatric disease, to nicotine addiction. Awareness of AChR involvement in some of these diseases has provoked new interests in development of therapeutic agonists for specific AChR subtypes and the use of expressed cloned AChR subunits as possible immunotherapeutic agents. Highlights of recent developments in these areas will be briefly reviewed.

Citing Articles

Imaging Cholinergic Receptors in the Brain by Positron Emission Tomography.

Zhang J, Fu H, Lin R, Zhou J, Haider A, Fang W J Med Chem. 2023; 66(16):10889-10916.

PMID: 37583063 PMC: 10461233. DOI: 10.1021/acs.jmedchem.3c00573.


Electrical neuromodulation therapy for inflammatory bowel disease.

Yasmin F, Sahito A, Lamiya Mir S, Khatri G, Shaikh S, Gul A World J Gastrointest Pathophysiol. 2022; 13(5):128-142.

PMID: 36187600 PMC: 9516456. DOI: 10.4291/wjgp.v13.i5.128.


Mice lacking α4 nicotinic acetylcholine receptors are protected against alcohol-associated liver injury.

Watson W, Ritzenthaler J, Torres-Gonzalez E, Arteel G, Roman J Alcohol Clin Exp Res. 2022; 46(8):1371-1383.

PMID: 35723023 PMC: 9427714. DOI: 10.1111/acer.14893.


Sulforaphane Suppresses the Nicotine-Induced Expression of the Matrix Metalloproteinase-9 via Inhibiting ROS-Mediated AP-1 and NF-κB Signaling in Human Gastric Cancer Cells.

Li S, Khoi P, Yin H, Sah D, Kim N, Lian S Int J Mol Sci. 2022; 23(9).

PMID: 35563563 PMC: 9099819. DOI: 10.3390/ijms23095172.


Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits.

Muderrisoglu A, Babaoglu E, Korkmaz E, Kalkisim S, Karabulut E, Emri S Front Genet. 2022; 13:812715.

PMID: 35222535 PMC: 8866864. DOI: 10.3389/fgene.2022.812715.


References
1.
Weiner H . Oral tolerance for the treatment of autoimmune diseases. Annu Rev Med. 1997; 48:341-51. DOI: 10.1146/annurev.med.48.1.341. View

2.
Hardy J . The Alzheimer family of diseases: many etiologies, one pathogenesis?. Proc Natl Acad Sci U S A. 1997; 94(6):2095-7. PMC: 33655. DOI: 10.1073/pnas.94.6.2095. View

3.
Anand R, Peng X, Ballesta J, Lindstrom J . Pharmacological characterization of alpha-bungarotoxin-sensitive acetylcholine receptors immunoisolated from chick retina: contrasting properties of alpha 7 and alpha 8 subunit-containing subtypes. Mol Pharmacol. 1993; 44(5):1046-50. View

4.
Lindstrom J, Merlie J, Yogeeswaran G . Biochemical properties of acteylcholine receptor subunits from Torpedo californica. Biochemistry. 1979; 18(21):4465-70. DOI: 10.1021/bi00588a003. View

5.
Wang Z, Link H, Ljungdahl A, Hojeberg B, Link J, He B . Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell Immunol. 1994; 157(2):353-68. DOI: 10.1006/cimm.1994.1233. View